- Home
- MLKN vs OCS Comparison
MLKN vs OCS Comparison
Compare MLKN & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLKN | OCS |
|---|---|---|
| Founded | 1905 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MLKN | OCS |
|---|---|---|
| Price | $20.23 | $26.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $39.57 |
| AVG Volume (30 Days) | ★ 537.0K | 202.7K |
| Earning Date | 12-17-2025 | 03-10-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,748,900,000.00 | $991,999.00 |
| Revenue This Year | $6.57 | $14.53 |
| Revenue Next Year | $4.45 | $691.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.34 | N/A |
| 52 Week Low | $13.77 | $14.00 |
| 52 Week High | $23.47 | $26.89 |
Technical Indicators
Market Signals| Indicator | MLKN | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 71.28 | 83.73 |
| Support Level | $18.76 | $22.60 |
| Resistance Level | $19.62 | $24.50 |
| Average True Range (ATR) | 0.62 | 1.30 |
| MACD | 0.01 | 0.52 |
| Stochastic Oscillator | 89.59 | 97.19 |
Price Performance
Historical ComparisonAbout MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.